Auxilium Pharmaceuticals, Inc. (AUXL) Tops Q4 EPS by 11c; Guides FY13

Article Related Press Releases (1) Related SEC Filings (1) Stock Quotes (1) Comments (0)

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) reported Q4 EPS of $1.83, $0.11 better than the analyst estimate of $1.72. Revenue for the quarter came in at $172.5 million versus the consensus estimate of $171.2 million.

Sees FY2013 revenue of $325-355 million, versus the consensus of $342.30 million. Net income on a non-GAAP basis will be in the range of $18 to $23 million.

For earnings history and earnings-related data on Auxilium Pharmaceuticals, Inc. (AUXL) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
• Aeropostale, Inc. (ARO) Tops Q1 EPS by 1c; Guide for Wide Q2 Loss
• UPDATE: Sears Holding Corp. (SHLD) Reports Q1 Loss of $1.29

Create E-mail Alert Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?